NCT02508584View on ClinicalTrials.gov

Personalized Immunotherapeutic for Antibiotic-resistant Infection

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

April 12, 2016

Primary Completion Date

June 12, 2019

Study Completion Date

June 12, 2019

Conditions
InfectionImmune DeficiencyHypogammaglobulinemiaSeptic ArthritisMycoplasma Hominis
Interventions
BIOLOGICAL

anti-mycoplasma hominis antibodies

provision of customized anti-mycoplasma hominis antibodies in the context of a treatment IND.

Trial Locations (1)

02115

Brigham and Women's Hosptial, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT02508584 - Personalized Immunotherapeutic for Antibiotic-resistant Infection | Biotech Hunter | Biotech Hunter